Table 3.

Bivariate Analysis for Continuous Retention and Viral Suppression at End of Follow-up

Variable	Total (n = 68)a,b
	Continuous Retention			Continuous Viral Suppressionc,d
	n/N	%	P	n/N	%	P
Overall	27/68	40		24/68	35
Age ≥ 45 y			.84			.94
Yes	13/37	37		13/35	37
No	14/33	42		11/33	33
Sex			.43			1
Male	21/48	44		17/48	35
Female	6/20	30		7/20	35
Race			.02			.17
Black	19/57	33		18/57	32
Not black	8/11	73		6/11	55
US born			.28			.31
Yes	17/49	35		15/49	31
No	10/19	53		9/19	47
English speaker			.24			.43
Yes	22/60	37		20/60	33
No	5/8	63		4/8	50
History of homelessness			.62			.20
Yes	12/34	35		9/34	26
No	15/34	44		15/34	44
History of incarceration			.99			.21
Yes	12/31	39		8/31	26
No	15/37	41		16/37	43
Employed			.05			≤.01
Yes	8/12	67		9/12	75
No	19/56	34		15/56	27
Insurance			1			.99
No insurance/ Ryan White	11/28	40		10/28	36
Other	16/40	40		14/40	35
Psychiatric disease			.76			1
Yes	9/20	45		7/20	35
No	18/48	38		17/48	35
Tobacco			.61			.10
Yes	16/44	36		12/44	27
No	11/24	46		12/24	50
Alcohol			.92			.77
Yes	14/37	38		12/37	32
No	13/31	42		12/31	39
Illicit drug use			1			.21
Yes	11/28	40		7/28	25
No	16/40	40		17/40	42
Known HIV prior to TB diagnosis			.76			.89
Yes	22/53	41		18/53	34
No	5/15	33		6/14	40
On ART prior to TB diagnosis			.99			.99
Yes	4/9	44		3/9	33
No	23/59	39		21/59	36
Baseline CD4 < 50			.59			.99
Yes	8/24	33		8/24	33
No	19/44	43		16/44	36
ART with DOT						.40
Yes	1/7	14		1/7	14
No	26/61	43		23/61	38
TB treatment duration ≥9 mo			.57			.10
Yes	17/46	37		13/46	28
No	10/22	45		11/22	50
Date TB diagnosise			.42			.64
<March 2012	13/38	34		12/38	32
≥March 2012	14/30	47		12/30	40
ART during TB therapy			.03			.08
Yes	26/57	46		23/57	40
No	1/11	9		1/11	9
VS end of TB therapy			.04			≤.01
Yes	20/39	51		20/39	51
No	7/29	24		4/29	14
On ART ≥6 mo prior to end of TB treatmentf			.88			.99
Yes	19/40	48		16/40	40
No	10/17	59		7/17	41

Abbreviations: ART, antiretroviral therapy; DOT, directly observed therapy; TB, tuberculosis; VS, viral suppression.

^aSixty-eight patients had ≥1 year of follow-up, 65 patients had ≥2 years of follow-up, and 53 patients had 3 years of follow-up.

^bSixty-seven unique subjects, no change in statistical significance when restricted to unique subjects.

^cSubjects with missing viral load assumed to have a viral load >200 copies/mL.

^dAmong 43 subjects without continuous viral suppression, 31 (72%) had ≥1 viral load >200 copies/mL and 12 (28%) did not have any viral load during follow-up. No change in statistical significance when missing viral load was treated as unknown.

^eNot significant when year of TB diagnosis was analyzed as a continuous variable.

^fAmong patients who received ART during TB treatment (n = 57).